1672-6731
2011 Issue 1
Efficacy of repetitive transcranial magnetic stimulation treatment with MPTP Parkinson\'s disease mice
WANG Mingwei;WANG Quandong;DONG Qiaoyun;QIANG Jing;MA Qinying
WANG Mingwei;WANG Quandong;DONG Qiaoyun;QIANG Jing;MA Qinying
..............page:65-70
Experimental study on the relationship between levodopa-induced dyskinesia and phosphorylation of ERK in the striatum
SONG Lu;MA Yaping;LIU Zhenguo;BA Maowen;BIAN Leisi
SONG Lu;MA Yaping;LIU Zhenguo;BA Maowen;BIAN Leisi
..............page:60-64
ji xing nao geng si huan zhe jing dong mai zhou yang ying hua cheng du ji qi xiang guan yin su fen xi
zhen zhi gang ; gao su ling
zhen zhi gang ; gao su ling
..............page:107-109
wai shang xing ying mo xia ji ye ji fa man xing ying mo xia xue zhong lin chuang fen xi
xiong hai yang ; jiang shi zuo ; ma jing ; wang zuo
xiong hai yang ; jiang shi zuo ; ma jing ; wang zuo
..............page:50
Clinical characteristics of dopa-responsive dystonia
SONG Wei;HUANG Rui;ZHAO Bi;ZHENG Zhenzhen;SHANG Huifang
SONG Wei;HUANG Rui;ZHAO Bi;ZHENG Zhenzhen;SHANG Huifang
..............page:93-95
an jie jie nao mo liu de xian wei shou shu zhi liao
liang xian kun ; li wen shuai ; zhang quan zhong ; guo xi wen ; wang zuo ; song jing yuan
liang xian kun ; li wen shuai ; zhang quan zhong ; guo xi wen ; wang zuo ; song jing yuan
..............page:111-112
An update comment on the diagnosis and treatment of Parkinson\'s disease
CHAN Piu;DING Hui
CHAN Piu;DING Hui
..............page:1-3
Advances in idiopathic basal ganglia calcification
ZHAO Yingchun
ZHAO Yingchun
..............page:27-29
jin xing xing kou she si zhi bu zi zhu yun dong
zhou li xin ; guan hong zhi ; ni jun ; wan xin hua ; chen lin ; cui li ying
zhou li xin ; guan hong zhi ; ni jun ; wan xin hua ; chen lin ; cui li ying
..............page:117-120
ji xing hua nong xing ji sui yan yi li
wang xiao ju ; zhang jian ping
wang xiao ju ; zhang jian ping
..............page:113-114
Subependymoma: a case report and the review of literatures
YANG Hui;BA Xiaoqun;KE Changshu
YANG Hui;BA Xiaoqun;KE Changshu
..............page:99-103
The release of lysosomal Pro-cathepsin L of BV-2 cells upon lipopolysaccharide stimulation and its toxicity to neurons
ZHANG Hui;LIU Guidong;LOU Yue;XIAO Qin;CHEN Shengdi
ZHANG Hui;LIU Guidong;LOU Yue;XIAO Qin;CHEN Shengdi
..............page:71-75
Analysis of the expression of normal and mutant full-length atrophin-1 gene in stable and transient transfected eukaryotic cell line
ZHANG Xin;GU Weihong;WANG Guoxiang
ZHANG Xin;GU Weihong;WANG Guoxiang
..............page:76-81
Pathogenesis and treatment of camptocormia in Parkinson\'s disease
RONG Tianyi;CHEN Shengdi
RONG Tianyi;CHEN Shengdi
..............page:15-17
Gait disorders: classification, diagnosis and treatment
GUI Huiwen;LIU Jun
GUI Huiwen;LIU Jun
..............page:18-21
Extraction and purification of tumorigenic Schwann cells in vitro from neurofibromatosis type 2 tissues
WANG Wei;YANG Xuejun;LI Yu;DONG Xuetao;WANG Huamin;MING Haolang;ZHANG Bin;YU shengping
WANG Wei;YANG Xuejun;LI Yu;DONG Xuetao;WANG Huamin;MING Haolang;ZHANG Bin;YU shengping
..............page:82-87
Research advances on multiple system atrophy
CHEN Xianwen
CHEN Xianwen
..............page:36-42
..............page:6,21,29,42,64,75,103,106,112,116,120-123
..............page:104-106
The molecular mechanisms of Huntington\'s disease and its advances in therapeutic strategies
YAN Yaping;ZHANG Baorong
YAN Yaping;ZHANG Baorong
..............page:30-35
Diagnosis and treatment of restless legs syndrome should be concerned
CHEN Shengdi;CHEN Sheng
CHEN Shengdi;CHEN Sheng
..............page:4-6
Research on progressive supranclear palsy
LIU Yiming;LI Jiazhen
LIU Yiming;LI Jiazhen
..............page:22-26
..............page:51-53
Change of olfactory function associated structures in Parkinson\'s disease: a voxel-based morphometry study
DING Hui;WU Xiaoli;ZHANG Kaiyuan;FAN Fengmei;ZHU Chaozhe;LI Kuncheng;CHAN Piu
DING Hui;WU Xiaoli;ZHANG Kaiyuan;FAN Fengmei;ZHU Chaozhe;LI Kuncheng;CHAN Piu
..............page:54-59
Progress in the study of botulinum toxin for the treatment of movement disorders
YANG Yingmai;WAN Xinhua
YANG Yingmai;WAN Xinhua
..............page:43-50
xiao er wai shang xing lu hou wo xue zhong lin chuang fen xi
yuan jun feng ; fan qi tao ; yuan xian hou ; jiang pu cha
yuan jun feng ; fan qi tao ; yuan xian hou ; jiang pu cha
..............page:109-111
Clinical analysis of ocular myasthenia gravis
MA Xiaowei;YANG Li;YANG Chunsheng;ZHANG Daqi;ZHAI Hui;CHENG Yan
MA Xiaowei;YANG Li;YANG Chunsheng;ZHANG Daqi;ZHAI Hui;CHENG Yan
..............page:88-92
Analysis of clinical manifestations and MRI features in multiple sclerosis involved with spinal cord
SHEN Xueli;LU Xi;ZHANG Simeng;CUI Mengyao
SHEN Xueli;LU Xi;ZHANG Simeng;CUI Mengyao
..............page:96-98
shen jing mei du si li lin chuang fen xi
liu bin ; zuo kun ; cui gui yun ; shen xia
liu bin ; zuo kun ; cui gui yun ; shen xia
..............page:114-116
Atypical parkinsonian disorders
huang yue ; chen sheng di ;gregor wenning;lawrence golbe; wang shao shi ; wang yong jun ; zhao gang ; lv pei yuan ; chen biao ;jun yu;christine song;andrew lees;irene litvan; wang xiao min ;glenda halliday
huang yue ; chen sheng di ;gregor wenning;lawrence golbe; wang shao shi ; wang yong jun ; zhao gang ; lv pei yuan ; chen biao ;jun yu;christine song;andrew lees;irene litvan; wang xiao min ;glenda halliday
..............page:7-14